封面
市場調查報告書
商品編碼
2144380

後生元食品配料市場預測至2034年-按配料類型、微生物來源、功能功效、應用、形態和地區分類的全球分析

Postbiotic Food Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Microbial Source, Functional Benefit, Application, Form, and Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,預計到 2026 年,全球後生元食品配料市場將達到 5 億美元,並在預測期內以 20.0% 的複合年成長率成長,到 2034 年達到 21.5 億美元。

後生元食品配料是指含有去活化微生物、微生物成分或微生物發酵代謝物的配方,這些成分被添加到食品和飲料中以達到功能性或營養性目的。與益生菌不同,後生元配料無需活微生物即可在產品的整個保存期限或食用期內存活。它們可以添加到機能飲料、乳製品、營養食品、膳食補充劑和其他配方中。其潛在優勢在於提高了配方的穩定性和相容性,即使在可能影響活微生物的加工和儲存條件下,也能保持穩定。人們對微生物組科學日益成長的興趣正在推動後生元配料的研究和商業化。製造商正在探索其在消化器官系統、免疫系統和整體健康方面的應用。發酵技術、微生物表徵、穩定化技術和配料加工技術的進步正在拓展後生元食品配方的應用前景。

市場動態

消費者對腸道健康和免疫力的需求日益成長

消費者對腸道健康和免疫支持的需求日益成長,推動了後生元食品配料的普及。人們對後生元在健康方面作用的認知不斷提高,也促進了市場擴張。後生元及其功效研究的進展推動了產品開發。消化器官系統和免疫系統健康問題的日益普遍,加速了產品的推廣應用。後生元正逐漸成為關鍵的功能性成分。

認知度低和監理挑戰

消費者對後生元功效的認知度較低以及監管方面的挑戰是限制市場成長的障礙。後生元的法律規範因地區而異。後生元強化產品的高定價可能會限制其在大眾市場的吸引力。配方方面的技術挑戰正在影響產品開發。消費者對後生元功效的懷疑態度可能會阻礙其普及。

後生元原料配方創新

後生元原料和配方的創新帶來了巨大的成長機會。穩定性和功能性增強的後生元的開發正在拓展其應用範圍。臨床研究後生元的日益普及正在增強消費者的信心。與食品飲料生產商的合作正在加速產品開發。技術進步不斷提升後生元的功能性。

與益生菌和益生元的競爭

益生菌和益生元的競爭可能會限制後生元成分的普及。經濟壓力可能會影響食品生產商對添加後生元的投資。影響後生元功效聲明的監管變化可能會對行銷產生負面影響。消費者對後生元功效的懷疑可能會影響其普及化。成熟品類的市場飽和可能會限制其成長。

新型冠狀病毒(COVID-19)的影響

新冠感染疾病加劇了人們對腸道健康和免疫力的關注,加速了對後生元食品原料的需求。消費者對腸道與免疫力之間關聯的認知不斷提高,推動了市場擴張。即使在疫情後時期,人們對後生元產品的興趣依然持續。疫情封鎖期間,電商通路促進了產品的供應。人們對預防醫學日益成長的興趣也促進了產品的普及。

在預測期內,去活化益生菌細胞細分市場預計將佔據最大佔有率。

預計在預測期內,去活化益生菌細胞將佔據最大的市場佔有率。這是因為與活性益生菌相比,去活化益生菌細胞具有更優異的穩定性和安全性。消費者對高穩定性、保存期限長的產品的需求不斷成長,推動了市場擴張。對去活化細胞的深入研究鞏固了該細分市場的領先地位。去活化益生菌細胞是應用最廣泛的後生元成分。

預計在預測期內,雙歧桿菌細分市場將呈現最高的複合年成長率。

在預測期內,雙歧桿菌細分市場預計將呈現最高的成長率,這主要得益於對雙歧桿菌來源的後生元及其健康益處的研究不斷深入。消費者對免疫和腸道健康產品的需求不斷成長,也推動了市場擴張。生產技術的進步提高了成本競爭力。雙歧桿菌來源的後生元正逐漸成為關鍵成分。

市佔率最大的地區

在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於消費者對腸道健康產品的高需求、後生元原料公司的強大實力以及發達的食品工業。美國擁有許多後生元原料公司,並具備成熟的生產能力。較高的可支配收入和日益增強的健康意識正在鞏固其在該地區市場的領先地位。對含後生元產品的需求不斷成長,正在推動全部區域這類產品的廣泛應用。

複合年成長率最高的地區

在預測期內,歐洲預計將呈現最高的複合年成長率,這主要得益於強力的腸道健康標籤監管支持、消費者對後生元認知度的提高以及對機能性食品需求的成長。歐盟政策正在支持後生元食品的發展。大量的研究經費和企業投資為技術進步提供了支撐。強烈的健康意識正在推動全部區域後生元成分的採用。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶要求,我們可以提供主要國家的市場估算和預測,以及複合年成長率(註:需進行可行性檢查)。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章:全球後生元食品配料市場:依配料類型分類

  • 去活化益生菌細胞
  • 微生物代謝產物
  • 短鏈脂肪酸
  • 微生物細胞成分
  • 發酵衍生化合物
  • 其他原料類型

第6章:全球後生元食品配料市場:依微生物來源分類

  • 乳酸桿菌
  • 雙歧桿菌
  • 乳酸菌
  • 酵母菌
  • 其他細菌
  • 其他微生物來源

第7章 全球後生元食品配料市場:依功能功效分類

  • 腸道健康
  • 免疫支持
  • 代謝健康
  • 發炎管理
  • 皮膚健康
  • 其他功能性益處

第8章:全球後生元食品配料市場:依應用領域分類

  • 乳製品和乳製品替代品
  • 飲料
  • 麵包糖果甜點
  • 機能性食品
  • 嬰幼兒營養食品
  • 其他

第9章:全球後生元食品配料市場:依形式分類

  • 粉末
  • 液體
  • 膠囊
  • 顆粒
  • 集中
  • 其他形式

第10章 全球後生元食品配料市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章:公司簡介

  • ADM
  • DSM-Firmenich AG
  • Novonesis A/S
  • Kerry Group plc
  • Ingredion Incorporated
  • Chr. Hansen Holding A/S
  • Lallemand Inc.
  • Kaneka Corporation
  • AB-BIOTICS SA
  • Paragon Laboratories
  • SAB Biotherapeutics
  • Probi AB
  • OptiBiotix Health plc
  • Lesaffre
  • Postbiotics Plus
Product Code: SMRC39811

According to Stratistics MRC, the Global Postbiotic Food Ingredients Market is accounted for $0.5 billion in 2026 and is expected to reach $2.15 billion by 2034 growing at a CAGR of 20.0% during the forecast period. Postbiotic Food Ingredients comprise preparations containing inactivated microorganisms, microbial components, or metabolites produced through microbial fermentation that are incorporated into foods and beverages for functional or nutritional purposes. Unlike probiotics, postbiotic ingredients do not require live microorganisms to remain viable throughout product storage and consumption. They can be incorporated into functional beverages, dairy products, nutritional foods, supplements, and other formulations. Their potential advantages include improved formulation stability and compatibility with products exposed to processing or storage conditions that may affect live cultures. Growing interest in microbiome science is supporting research and commercialization of postbiotic ingredients. Manufacturers are exploring applications related to digestive, immune, and general wellness. Advances in fermentation, microbial characterization, stabilization, and ingredient processing are expanding opportunities for postbiotic food formulations.

Market Dynamics

Driver:

Growing consumer demand for gut health and immunity

Increasing consumer demand for gut health and immune support is driving adoption of postbiotic food ingredients. Growing awareness of the role of postbiotics in health supports market expansion. Advances in research on postbiotics and their benefits drive product development. Rising prevalence of digestive and immune health issues accelerates product adoption. Postbiotics are emerging as key functional ingredients.

Restraint:

Limited awareness and regulatory challenges

Limited consumer awareness of postbiotic benefits and regulatory challenges present barriers to market growth. Regulatory frameworks for postbiotics vary significantly across regions. Price premiums for postbiotic-fortified products may limit mass-market appeal. Technical challenges in formulation affect product development. Consumer skepticism regarding postbiotic benefits may affect adoption.

Opportunity:

Innovation in postbiotic ingredients and formulations

Innovation in postbiotic ingredients and formulations presents significant growth opportunities. Development of postbiotics with improved stability and functionality is expanding applications. Growing availability of clinically studied postbiotics is building consumer confidence. Partnerships with food and beverage manufacturers accelerate product development. Technology advances continue improving postbiotic functionality.

Threat:

Competition from probiotics and prebiotics

Competition from probiotics and prebiotics may limit adoption of postbiotic ingredients. Economic pressures may affect food manufacturers' investment in postbiotic fortification. Regulatory changes affecting postbiotic claims may impact marketing. Consumer skepticism regarding postbiotic benefits may affect adoption. Market saturation in mature categories may constrain growth.

Covid-19 Impact:

The COVID-19 pandemic increased focus on gut health and immunity, accelerating demand for postbiotic food ingredients. Growing consumer awareness of the gut-immune connection supports market expansion. The post-pandemic period has witnessed sustained interest in postbiotic products. E-commerce channels facilitated product access during lockdowns. Growing focus on preventive health drives product adoption.

The inactivated probiotic cells segment is expected to be the largest during the forecast period

The inactivated probiotic cells segment is expected to account for the largest market share during the forecast period as inactivated probiotic cells offer stability and safety advantages over live probiotics. Growing consumer demand for stable, shelf-stable products drives market expansion. Established research on inactivated cells supports segment leadership. Inactivated probiotic cells are the most widely used postbiotic ingredient.

The Bifidobacterium segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Bifidobacterium segment is predicted to witness the highest growth rate driven by increasing research on Bifidobacterium-derived postbiotics and their health benefits. Growing consumer demand for immune and gut health products supports market expansion. Advances in production technology improve cost competitiveness. Bifidobacterium postbiotics are emerging as key ingredients.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to high consumer demand for gut health products, strong presence of postbiotic ingredient companies, and advanced food industry. The United States hosts major postbiotic ingredient companies with established production capabilities. High disposable incomes and health consciousness reinforce regional market leadership. Growing demand for postbiotic-fortified products drives adoption across the region.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by strong regulatory support for gut health claims, growing consumer awareness of postbiotics, and increasing demand for functional foods. European Union policies support postbiotic food development. Significant research funding and corporate investment support technology development. Strong health culture drives adoption of postbiotic ingredients across the region.

Key players in the market

Some of the key players in the Postbiotic Food Ingredients Market include ADM, DSM-Firmenich AG, Novonesis A/S, Kerry Group plc, Ingredion Incorporated, Chr. Hansen Holding A/S, Lallemand Inc., Kaneka Corporation, AB-BIOTICS S.A., Paragon Laboratories, SAB Biotherapeutics, Probi AB, OptiBiotix Health plc, Lesaffre, and Postbiotics Plus.

Key Developments:

In May 2025, ADM launched a new generation of postbiotic ingredients with enhanced stability and functionality for gut health applications. The ingredients offer improved shelf-life and efficacy. The development responds to growing demand for postbiotic solutions.

In April 2025, DSM-Firmenich AG announced significant expansion of its postbiotic ingredient portfolio with new products for immune and metabolic health.

Ingredient Types Covered:

  • Inactivated Probiotic Cells
  • Microbial Metabolites
  • Short-Chain Fatty Acids
  • Microbial Cell Components
  • Fermentation-Derived Compounds
  • Other Ingredient Types

Microbial Sources Covered:

  • Lactobacillus
  • Bifidobacterium
  • Lactic Acid Bacteria
  • Yeasts
  • Other Bacteria
  • Other Microbial Sources

Functional Benefits Covered:

  • Gut Health
  • Immune Support
  • Metabolic Health
  • Inflammation Management
  • Skin Health
  • Other Functional Benefits

Applications Covered:

  • Dairy & Dairy Alternatives
  • Beverages
  • Bakery & Confectionery
  • Functional Foods
  • Infant Nutrition
  • Other Applications

Forms Covered:

  • Powder
  • Liquid
  • Capsules
  • Granules
  • Concentrates
  • Other Forms

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Postbiotic Food Ingredients Market, By Ingredient Type

  • 5.1 Inactivated Probiotic Cells
  • 5.2 Microbial Metabolites
  • 5.3 Short-Chain Fatty Acids
  • 5.4 Microbial Cell Components
  • 5.5 Fermentation-Derived Compounds
  • 5.6 Other Ingredient Types

6 Global Postbiotic Food Ingredients Market, By Microbial Source

  • 6.1 Lactobacillus
  • 6.2 Bifidobacterium
  • 6.3 Lactic Acid Bacteria
  • 6.4 Yeasts
  • 6.5 Other Bacteria
  • 6.6 Other Microbial Sources

7 Global Postbiotic Food Ingredients Market, By Functional Benefit

  • 7.1 Gut Health
  • 7.2 Immune Support
  • 7.3 Metabolic Health
  • 7.4 Inflammation Management
  • 7.5 Skin Health
  • 7.6 Other Functional Benefits

8 Global Postbiotic Food Ingredients Market, By Application

  • 8.1 Dairy & Dairy Alternatives
  • 8.2 Beverages
  • 8.3 Bakery & Confectionery
  • 8.4 Functional Foods
  • 8.5 Infant Nutrition
  • 8.6 Other Applications

9 Global Postbiotic Food Ingredients Market, By Form

  • 9.1 Powder
  • 9.2 Liquid
  • 9.3 Capsules
  • 9.4 Granules
  • 9.5 Concentrates
  • 9.6 Other Forms

10 Global Postbiotic Food Ingredients Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 ADM
  • 13.2 DSM-Firmenich AG
  • 13.3 Novonesis A/S
  • 13.4 Kerry Group plc
  • 13.5 Ingredion Incorporated
  • 13.6 Chr. Hansen Holding A/S
  • 13.7 Lallemand Inc.
  • 13.8 Kaneka Corporation
  • 13.9 AB-BIOTICS S.A.
  • 13.10 Paragon Laboratories
  • 13.11 SAB Biotherapeutics
  • 13.12 Probi AB
  • 13.13 OptiBiotix Health plc
  • 13.14 Lesaffre
  • 13.15 Postbiotics Plus

List of Tables

  • Table 1 Global Postbiotic Food Ingredients Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Postbiotic Food Ingredients Market, By Ingredient Type (2023-2034) ($MN)
  • Table 3 Global Postbiotic Food Ingredients Market, By Inactivated Probiotic Cells (2023-2034) ($MN)
  • Table 4 Global Postbiotic Food Ingredients Market, By Microbial Metabolites (2023-2034) ($MN)
  • Table 5 Global Postbiotic Food Ingredients Market, By Short-Chain Fatty Acids (2023-2034) ($MN)
  • Table 6 Global Postbiotic Food Ingredients Market, By Microbial Cell Components (2023-2034) ($MN)
  • Table 7 Global Postbiotic Food Ingredients Market, By Fermentation-Derived Compounds (2023-2034) ($MN)
  • Table 8 Global Postbiotic Food Ingredients Market, By Other Ingredient Types (2023-2034) ($MN)
  • Table 9 Global Postbiotic Food Ingredients Market, By Microbial Source (2023-2034) ($MN)
  • Table 10 Global Postbiotic Food Ingredients Market, By Lactobacillus (2023-2034) ($MN)
  • Table 11 Global Postbiotic Food Ingredients Market, By Bifidobacterium (2023-2034) ($MN)
  • Table 12 Global Postbiotic Food Ingredients Market, By Lactic Acid Bacteria (2023-2034) ($MN)
  • Table 13 Global Postbiotic Food Ingredients Market, By Yeasts (2023-2034) ($MN)
  • Table 14 Global Postbiotic Food Ingredients Market, By Other Bacteria (2023-2034) ($MN)
  • Table 15 Global Postbiotic Food Ingredients Market, By Other Microbial Sources (2023-2034) ($MN)
  • Table 16 Global Postbiotic Food Ingredients Market, By Functional Benefit (2023-2034) ($MN)
  • Table 17 Global Postbiotic Food Ingredients Market, By Gut Health (2023-2034) ($MN)
  • Table 18 Global Postbiotic Food Ingredients Market, By Immune Support (2023-2034) ($MN)
  • Table 19 Global Postbiotic Food Ingredients Market, By Metabolic Health (2023-2034) ($MN)
  • Table 20 Global Postbiotic Food Ingredients Market, By Inflammation Management (2023-2034) ($MN)
  • Table 21 Global Postbiotic Food Ingredients Market, By Skin Health (2023-2034) ($MN)
  • Table 22 Global Postbiotic Food Ingredients Market, By Other Functional Benefits (2023-2034) ($MN)
  • Table 23 Global Postbiotic Food Ingredients Market, By Application (2023-2034) ($MN)
  • Table 24 Global Postbiotic Food Ingredients Market, By Dairy & Dairy Alternatives (2023-2034) ($MN)
  • Table 25 Global Postbiotic Food Ingredients Market, By Beverages (2023-2034) ($MN)
  • Table 26 Global Postbiotic Food Ingredients Market, By Bakery & Confectionery (2023-2034) ($MN)
  • Table 27 Global Postbiotic Food Ingredients Market, By Functional Foods (2023-2034) ($MN)
  • Table 28 Global Postbiotic Food Ingredients Market, By Infant Nutrition (2023-2034) ($MN)
  • Table 29 Global Postbiotic Food Ingredients Market, By Other Applications (2023-2034) ($MN)
  • Table 30 Global Postbiotic Food Ingredients Market, By Form (2023-2034) ($MN)
  • Table 31 Global Postbiotic Food Ingredients Market, By Powder (2023-2034) ($MN)
  • Table 32 Global Postbiotic Food Ingredients Market, By Liquid (2023-2034) ($MN)
  • Table 33 Global Postbiotic Food Ingredients Market, By Capsules (2023-2034) ($MN)
  • Table 34 Global Postbiotic Food Ingredients Market, By Granules (2023-2034) ($MN)
  • Table 35 Global Postbiotic Food Ingredients Market, By Concentrates (2023-2034) ($MN)
  • Table 36 Global Postbiotic Food Ingredients Market, By Other Forms (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.